V
Vir Biotechnology, Inc.
VIR · NASDAQ · Healthcare · 1.6B
Closing price
$11.70
+5.22% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
-3.7×
Free cash flow yieldFCF yield
-24.5%
Return on equityROE
-57.2%
Operating margin
-682.7%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.